Assessing activity of pediatric Crohn's disease: which index to use?

A Otley1, H Loonen, N Parekh

  • 1Division of Gastroenterology/Clinical Nutrition, The Hospital for Sick Children, Department of Pediatrics, University of Toronto, Toronto, Canada.

Gastroenterology
|February 25, 1999
PubMed

Insights

The Pediatric Crohn's Disease Activity Index (PCDAI) better distinguishes pediatric Crohn's disease activity levels than the adult Crohn's Disease Activity Index (CDAI). PCDAI shows stronger correlations with key inflammation markers.

Area of Science:

  • Pediatric Gastroenterology
  • Inflammatory Bowel Disease Research
  • Clinical Assessment Tools

Background:

  • The Pediatric Crohn's Disease Activity Index (PCDAI) was developed for pediatric patients, incorporating growth and laboratory markers.
  • The adult Crohn's Disease Activity Index (CDAI) relies more on subjective symptoms.

Purpose of the Study:

  • To compare the feasibility, validity, and responsiveness of PCDAI versus CDAI in pediatric Crohn's disease.
  • To determine which index better assesses disease activity in children and adolescents.

Main Methods:

  • Eighty-one pediatric patients with Crohn's disease were evaluated.
  • Gastroenterologists provided global assessments of disease activity (quiescent to severe).
  • CDAI and PCDAI scores were calculated independently.

Main Results:

  • Both PCDAI and CDAI showed significant differences in scores across disease activity levels.
  • PCDAI demonstrated less score overlap between strata compared to CDAI.
  • PCDAI correlated better with serum orosomucoid and platelet count.

Conclusions:

  • Both PCDAI and CDAI are effective in reflecting disease activity in pediatric Crohn's disease.
  • PCDAI exhibits superior ability in discriminating between varying levels of disease activity in pediatric patients.
Abstract

Related Concept Videos

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
Assessment of the Gastrointestinal System I: Subjective Data01:17

Assessment of the Gastrointestinal System I: Subjective Data

Assessing the gastrointestinal (GI) system is a complex process that begins with collecting subjective data. This data, collected through patient interviews, provides crucial insights into the patient's health history, perception patterns, and lifestyle habits, all contributing significantly to GI health.
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems related to...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...